Biomarkers of Stroke: Its Utility in Routine Clinical Practice.
作者信息
Maurya Pradeep Kumar
机构信息
Department of Neurology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
出版信息
J Neurosci Rural Pract. 2022 Apr 21;13(2):174-175. doi: 10.1055/s-0042-1744229. eCollection 2022 Apr.
Abstract
摘要
相似文献
1
Biomarkers of Stroke: Its Utility in Routine Clinical Practice.中风的生物标志物：其在常规临床实践中的效用。
J Neurosci Rural Pract. 2022 Apr 21;13(2):174-175. doi: 10.1055/s-0042-1744229. eCollection 2022 Apr.
2
Biomarkers of Angiogenesis and Neuroplasticity as Promising Clinical Tools for Stroke Recovery Evaluation.血管生成和神经可塑性的生物标志物作为评估中风康复的有前途的临床工具。
Int J Mol Sci. 2021 Apr 11;22(8):3949. doi: 10.3390/ijms22083949.
3
Invited article: searching for oracles? Blood biomarkers in acute stroke.特邀文章：寻找神谕？急性卒中中的血液生物标志物
Neurology. 2009 Aug 4;73(5):393-9. doi: 10.1212/WNL.0b013e3181b05ef9.
4
Prediction of motor recovery after stroke: advances in biomarkers.脑卒中后运动功能恢复的预测：生物标志物的研究进展。
Lancet Neurol. 2017 Oct;16(10):826-836. doi: 10.1016/S1474-4422(17)30283-1. Epub 2017 Sep 12.
5
Screening for mood disorders after stroke: a systematic review of psychometric properties and clinical utility.中风后情绪障碍的筛查：心理测量特性和临床效用的系统评价
Psychol Med. 2015 Jan;45(1):29-49. doi: 10.1017/S0033291714000336. Epub 2014 Feb 27.
6
Biomarkers of Stroke Recovery: Consensus-Based Core Recommendations from the Stroke Recovery and Rehabilitation Roundtable.脑卒中康复的生物标志物：脑卒中康复与修复圆桌会议达成的基于共识的核心建议。
Neurorehabil Neural Repair. 2017 Oct-Nov;31(10-11):864-876. doi: 10.1177/1545968317732680.
7
RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.RNA-Seq 鉴定出循环 miR-125a-5p、miR-125b-5p 和 miR-143-3p 可作为急性缺血性脑卒中的潜在生物标志物。
Circ Res. 2017 Sep 29;121(8):970-980. doi: 10.1161/CIRCRESAHA.117.311572. Epub 2017 Jul 19.
8
Biomarkers of stroke recovery: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable.中风恢复的生物标志物：中风恢复与康复圆桌会议基于共识的核心建议。
Int J Stroke. 2017 Jul;12(5):480-493. doi: 10.1177/1747493017714176.
9
Blood Biomarkers for the Differentiation of Cardiac Ischemic Stroke Subtypes: A Systematic Review.用于区分心脏缺血性卒中亚型的血液生物标志物：一项系统综述
Cardiovasc Hematol Disord Drug Targets. 2019;19(3):215-227. doi: 10.2174/1871529X18666180829142354.
10
Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke.缺血性脑卒中后预后的炎症和神经内分泌生物标志物。
Expert Rev Neurother. 2011 Feb;11(2):225-39. doi: 10.1586/ern.10.200.
本文引用的文献
1
Serum S100B and NSE Levels Correlate With Infarct Size and Bladder-Bowel Involvement Among Acute Ischemic Stroke Patients.急性缺血性中风患者血清S100B和NSE水平与梗死面积及膀胱直肠受累情况相关。
J Neurosci Rural Pract. 2022 Mar 9;13(2):218-225. doi: 10.1055/s-0042-1743214. eCollection 2022 Apr.
2
Acute Stroke Biomarkers: Are We There Yet?急性中风生物标志物：我们做到了吗？
Front Neurol. 2021 Feb 5;12:619721. doi: 10.3389/fneur.2021.619721. eCollection 2021.
3
Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis.用于中风诊断和鉴别诊断的血液生物标志物：系统评价和荟萃分析。
Int J Stroke. 2020 Oct;15(7):704-721. doi: 10.1177/1747493020946157. Epub 2020 Aug 3.
4
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.急性缺血性脑卒中患者早期管理指南：2018 年急性缺血性脑卒中早期管理指南的更新：美国心脏协会/美国卒中协会发布的医疗保健专业人员指南。
Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211. Epub 2019 Oct 30.
5
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.神经元特异性烯醇化酶作为一种生物标志物：生化与临床方面
Adv Exp Med Biol. 2015;867:125-43. doi: 10.1007/978-94-017-7215-0_9.
6
Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases.神经疾病患者血液中的胶质纤维酸性蛋白（GFAP）水平。
PLoS One. 2013 Apr 23;8(4):e62101. doi: 10.1371/journal.pone.0062101. Print 2013.
7
The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.生物液中的 S100B 蛋白：远不止是脑损伤的终身生物标志物。
J Neurochem. 2012 Mar;120(5):644-59. doi: 10.1111/j.1471-4159.2011.07612.x. Epub 2012 Jan 23.
8
Barriers of thrombolysis therapy in developing countries.发展中国家溶栓治疗的障碍。
Stroke Res Treat. 2011;2011:686797. doi: 10.4061/2011/686797. Epub 2011 Mar 17.
9
Molecular biomarkers in stroke diagnosis and prognosis.中风诊断与预后中的分子生物标志物
Biomark Med. 2009 Aug 1;3(4):363-383. doi: 10.2217/bmm.09.30.
10
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.利用血浆生物标志物对缺血性卒中亚型进行病因诊断。
Stroke. 2008 Aug;39(8):2280-7. doi: 10.1161/STROKEAHA.107.505354. Epub 2008 Jun 5.
Zotero 插件